Stay updated on Cetuximab and Pembrolizumab in Colorectal Cancer Clinical Trial

Sign up to get notified when there's something new on the Cetuximab and Pembrolizumab in Colorectal Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cetuximab and Pembrolizumab in Colorectal Cancer Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The page’s version label has been updated from “Revision: v3.5.2” to “Revision: v3.5.3,” indicating a new site release. No changes to the underlying study content are reflected.
    Difference
    0.1%
    Check dated 2026-04-25T17:57:29.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    The page now shows revision v3.5.2 and no longer lists v3.5.0.
    Difference
    0.1%
    Check dated 2026-04-18T13:19:46.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    Publications section updated: added the 2026 Int J Cancer paper on TP53 mutation and removed the earlier Int J Cancer entry.
    Difference
    0.1%
    Check dated 2026-04-11T10:21:16.000Z thumbnail image
  4. Check
    40 days ago
    Change Detected
    Summary
    The site revision label in the footer has been updated from v3.4.3 to v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-20T19:52:51.000Z thumbnail image
  5. Check
    47 days ago
    Change Detected
    Summary
    Added a Publications subsection including the Int J Cancer article on TP53 mutation and cetuximab/pembrolizumab. Noted that publications are automatically filled from PubMed.
    Difference
    0.3%
    Check dated 2026-03-13T20:16:40.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    Revision: v3.4.3 appears on the page, replacing v3.4.2; this is a minor update and does not modify study content.
    Difference
    0.1%
    Check dated 2026-03-06T17:50:15.000Z thumbnail image

Stay in the know with updates to Cetuximab and Pembrolizumab in Colorectal Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cetuximab and Pembrolizumab in Colorectal Cancer Clinical Trial page.